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Deletional Analysis of the rod Photoreceptor Cell Peripherin/RDS CarboxyTerminal Region
Abstract
The C-terminal region of peripherin/rds contains three predicted α-helical domains. One of these
domains, corresponding to amino acids 311-322, form an amphiphilic α-helix previously shown to
promote membrane fusion. The present studies were conducted to determine how the additional α-helical
regions of the peripherin/rds C-terminus affect complex formation with rom-1, glycosylation, intracellular
localization and membrane fusion properties. Bovine peripherin/rds and rom-1 were epitope tagged with
an amino-terminal FLAG-tag or amino-terminal hemagglutinin (HA)-tag, respectively, and cloned into the
pCI-neo expression vector for transient transfection into COS cells. Similarly, four C-terminal peripherin/
rds truncation mutants (Δ1, Δ2, Δ3 and Δ4), corresponding to deletions of -19, -29, -39 and -59 amino
acids were designed to disrupt the α-helical domains. Immunofluorescence microscopy and enzymatic
digestions demonstrated that full-length peripherin/rds and the four C-terminal deletion mutants were
localized to intracellular membranes and were all Endo-H sensitive. Western blotting and
immunoprecipitation studies showed that the FLAG-tagged bovine peripherin/rds (full-length) was
expressed as a 76 kDa dimer, which associates with HA-tagged rom-1 to form a higher order complex.
The deletion mutants were also able to associate with rom-1. However, when analyzed using nondenaturing tricine electrophoresis, full-length peripherin/rds and the Δ1, Δ2 and Δ3 mutants formed
homo-oligomeric complexes, while the Δ4 mutant appeared to form only homodimers suggesting a
region upstream of amino acid 300 may be involved in C-terminal interactions. Membrane fusion was
then evaluated using fluorescence resonance energy transfer (RET) techniques. Intracellular COS cell
membranes containing full-length peripherin/rds fused with rod outer segment plasma membrane
vesicles. This fusion was inhibited with the addition of a synthetic peptide (PP-5) corresponding to the
fusion domain of peripherin/rds. In contrast, fusion was negligible with any of the C-terminal truncation
mutants. Collectively, these results suggest that in addition to the fusion domain, other regions of the
peripherin/rds C-terminus are required for fusion. Most interesting is the observation that the last 19
amino acids, a region downstream of the fusion peptide that is deleted in the Δ1 mutant, appear to be
necessary for fusion. This region corresponds to the epitope for anti-peripherin/rds monoclonal antibody
2B6, which is shown to partially inhibit peripherin/rds mediated membrane fusion. © 2002 Elsevier
Science Ltd.
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The C-terminal region of peripherin/rds contains three predicted a-helical domains. One of these
domains, corresponding to amino acids 311±322, form an amphiphilic a-helix previously shown to
promote membrane fusion. The present studies were conducted to determine how the additional
a-helical regions of the peripherin/rds C-terminus affect complex formation with rom-1, glycosylation,
intracellular localization and membrane fusion properties. Bovine peripherin/rds and rom-1 were
epitope tagged with an amino-terminal FLAG-tag or amino-terminal hemagglutinin (HA)-tag,
respectively, and cloned into the pCI-neo expression vector for transient transfection into COS cells.
Similarly, four C-terminal peripherin/rds truncation mutants (D1, D2, D3 and D4), corresponding to
deletions of -19, -29, -39 and -59 amino acids were designed to disrupt the a-helical domains.
Immuno¯uorescence microscopy and enzymatic digestions demonstrated that full-length peripherin/rds
and the four C-terminal deletion mutants were localized to intracellular membranes and were all Endo-H
sensitive. Western blotting and immunoprecipitation studies showed that the FLAG-tagged bovine
peripherin/rds (full-length) was expressed as a 76 kDa dimer, which associates with HA-tagged rom-1
to form a higher order complex. The deletion mutants were also able to associate with rom-1. However,
when analyzed using non-denaturing tricine electrophoresis, full-length peripherin/rds and the D1, D2
and D3 mutants formed homo-oligomeric complexes, while the D4 mutant appeared to form only
homodimers suggesting a region upstream of amino acid 300 may be involved in C-terminal
interactions. Membrane fusion was then evaluated using ¯uorescence resonance energy transfer (RET)
techniques. Intracellular COS cell membranes containing full-length peripherin/rds fused with rod outer
segment plasma membrane vesicles. This fusion was inhibited with the addition of a synthetic peptide
(PP-5) corresponding to the fusion domain of peripherin/rds. In contrast, fusion was negligible with any
of the C-terminal truncation mutants. Collectively, these results suggest that in addition to the fusion
domain, other regions of the peripherin/rds C-terminus are required for fusion. Most interesting is the
observation that the last 19 amino acids, a region downstream of the fusion peptide that is deleted in the
D1 mutant, appear to be necessary for fusion. This region corresponds to the epitope for anti-peripherin/
rds monoclonal antibody 2B6, which is shown to partially inhibit peripherin/rds mediated membrane
# 2002 Elsevier Science Ltd.
fusion.
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1. Introduction
The retinal degeneration slow or rds mouse is a model
for a group of inherited human diseases known
collectively as retinitis pigmentosa (van Nie et al.,
1978). Mice homozygous for the rds mutation do not
develop photoreceptor outer segments and exhibit a
slow progressive loss of rods and cones (Sanyal and
Jansen, 1981). The underlying defect is an insertion
of a 9.2 kbp repetitive sequence element into a gene
known as peripherin/rds (Travis et al., 1989).
Subsequent studies have shown that mutations in
the human peripherin/rds gene also cause a variety of
retinal dystrophies including autosomal dominant
retinitis pigmentosa and macular dystrophy (Kohl
et al., 1998).
* Author for correspondence. E-mail: muller@umdnj.edu
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Peripherin/rds is a 346 amino acid integral membrane glycoprotein expressed exclusively in the outer
segments of rod and cone cells (Connell and Molday,
1990; Travis et al., 1991). Within the photoreceptor
disk rim, peripherin/rds is oriented such that both the
N-terminus and C-terminus are exposed to the
cytoplasm (Arikawa et al., 1992). The protein has
four predicted transmembrane domains and consequently two intradiskal loops (D1 and D2). The D1
loop is located between the ®rst and second transmembrane domains while the D2 loop, the larger of the two,
is located between the third and fourth transmembrane
domains. Peripherin/rds is highly conserved with
amino acid identities of greater than 90 % between
species (Kedzierski et al., 1996). It has two potential
N-linked glycosylation sites although only asparagine
229 is glycosylated in vivo (Kedzierski et al., 1999).
# 2002 Elsevier Science Ltd.
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In rod outer segment (ROS) disk membranes,
peripherin/rds forms disul®de-linked homodimers,
via cysteine residue 150 located within the D2 loop
(Goldberg et al., 1998). A signi®cant portion of these
homodimers form disul®de-linked homotetrameric
and octameric complexes (Loewen and Molday,
2000). Peripherin/rds homodimers also associate
with homodimers of the related disk rim protein,
rom-1 to form multisubunit complexes (Travis et al.,
1991; Goldberg et al., 1995; Goldberg and Molday,
1996). Rom-1 is a 37 kDa, non-glycosylated structural homolog of peripherin/rds that is expressed in
the rim region of rod disk membranes (Bascom et al.,
1992; Moritz and Molday, 1996). Although the
function(s) of peripherin/rds remains elusive, it is
proposed to serve an important role in the structural
maintenance of rod and cone outer segments (Travis
et al., 1991; Bascom et al., 1992; Goldberg et al.,
1995). This is directly supported by in vitro studies
showing that expression of peripherin/rds confers a
¯attened morphology upon microsomal membranes
(Wrigley et al., 2000). More recently, Poetsch et al.
(2001) have shown that peripherin/rds interacts
with glutamic acid rich proteins (GARP) associated
with the b-subunit of the cGMP-gated channel located
in ROS plasma membranes.
While the D-2 loop of peripherin/rds (the region
containing the highest concentration of disease-linked
mutations) has been well characterized, very little is
known about this proteins' C-terminal domain. One
postulated function for the peripherin/rds C-terminus
is that of a membrane fusion protein. In ROS,
membrane fusion events are necessary for both disk
morphogenesis and shedding (Steinberg et al., 1980;
Matsumoto and Besharse, 1995). Puri®ed, native
peripherin/rds has been shown to promote fusion of
recombinant disk lipid vesicles with ROS plasma
membrane vesicles (Boesze-Battaglia et al., 1998).
The putative fusion domain is an amphiphilic
a-helical region located within the peripherin/rds
C-terminus. Notably, a synthetic peptide (PP-5)
corresponding to this 15 amino acid fusion domain,
can mediate individual steps of membrane fusion
including aggregation and membrane destabilization
(Boesze-Bataglia et al., 1998, 2000).
In addition to the fusion domain, there are two other
predicted a-helical domains located within the peripherin/rds C-terminus. This region may not only be
involved in membrane fusion processes, but is
proposed to contain a ROS speci®c localization signal
(based on green ¯uorescent protein (GFP)-fusion
constructs) (Tam et al., 2001). Its importance is also
illustrated clinically by several chain termination and
frame-shift mutations that result in proteins lacking
various portions of the C-terminus. Individuals
that have inherited these mutations present with
heterogeneous disease phenotypes including pattern
dystrophy and vitelliform macular dystrophy (Felbor
et al., 1997; Kohl et al., 1997). Here we employ a
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well-characterized COS cell expression system to
evaluate the contribution of the C-terminal a-helices
to the established biochemical properties of peripherin/rds. A series of C-terminal deletion mutants were
generated and shown to retain the capacity to interact
with rom-1, although none are able to promote
membrane fusion. Collectively, these results suggest
that along with the fusion domain, other a-helical
regions of the C-terminus contribute to the membrane
fusion process. We propose that progressive deletion of
the C-terminus abrogates the formation of a fusion
competent peripherin/rds.
2. Materials and Methods
Generation of Peripherin/rds and Rom-1 Plasmid
Constructs
The open reading frames of peripherin/rds and
rom-1 were isolated from bovine retinal mRNA using
RT±PCR (Ausubel, 1999). Peripherin/rds primers were
designed using the sequence provided by Connell and
Molday (1990, Genbank accession J02884). To enable
protein detection, the upper 50 primer was engineered
with a 24-nucleotide sequence corresponding to an 8
amino acid FLAG epitope tag (50 -ATGGACTAGAAGGACGACGACGACAAGGCGCTGCTCAAAGTCAAATTT-30 ). The lower 30 primer corresponded to the
following sequence: 50 -CTTCAGTGTGCAGAGGGGACT-30 . Similarly, rom-1 primers were designed
using the sequence provided by Moritz and Molday
(1996, Genbank accession U72027). The upper 50
primer was engineered with a 36-nucleotide sequence
corresponding to a 13 amino acid hemagglutinin (HA)
epitope tag (50 -ATGTGCTACCCTTACGACGTGCCTGACTACGCCAGCCTGGCGCCGGTGCTGCCCCTGGTC30 ). The rom-1 lower 30 primer was 50 -CTAGGCCTCAGGCAGACACTCCTTGG-30 . All reactions were carried out for 35 cycles using an annealing temperature
of 638C. The resulting PCR products were puri®ed,
kinased and end-®lled by standard procedures (Sambrook et al., 1989). The fragments were then ligated to
Sma I-digested pCI-Neo vector (Promega, Madison, WI,
U.S.A.) and veri®ed by DNA sequencing.
To generate the peripherin/rds deletion mutants,
four additional lower 30 primers were designed. These
primers correspond to progressive deletions of the
C-terminus and are presented below:
30 Lower PCR primer

Deletion
number
D1
D2
D3
D4

50
50
50
50

-

TCACAGCTTCTTCACACTCTCCAGAAA - 30
TCACTTCCAGGTCTCCGGCACGC - 30
TCAAAGCCAGCCCTCACTCTCGCAC - 30
TCAGTGCAGGTAGCGTAGCCCAA - 30

Each 30 primer was used in conjunction with the
FLAG-tagged peripherin/rds 50 primer to amplify the
speci®c DNA fragments. All PCR reactions were
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performed for 35 cycles using an annealing temperature of 608C and peripherin/rds/pCI-Neo construct as
template DNA. Following PCR, the fragments were
manipulated as described above and ligated to Sma
I-digested pCI-Neo vector. All plasmid constructs were
veri®ed by sequence analysis and puri®ed by density
gradient centrifugation (Sambrook et al., 1989).
Cell Culture and Transfections
COS cells were grown in Dulbecco's Modi®ed
Essential Media (DMEM) supplemented with 10 %
fetal bovine serum. The cells were maintained in a
humidi®ed atmosphere of 5.5 % CO2 at 378C and split
1 : 3 every third or fourth day. Transfections were
performed using Lipofectamine PLUS reagent (Invitrogen Life Technologies, Carlsbad, CA, U.S.A.) as
directed by the manufacturer. Cells were seeded 1 day
prior to transfection as follows; 1  105 cells per well
in a six well plate, 1  106 cells/10 cm dish, or
3  106 cells/15 cm dish. The amount of plasmid
DNA was likewise based on culture vessel size; 1 mg
per well, 4 mg/10 cm dish, or 12 mg/15 cm dish. All
cells were harvested 48 hr post-transfection.
Immunolocalization and Immunoprecipitation Analysis
Immunolocalization studies were performed as
described previously (Caradonna et al., 1996).
The M5 anti-FLAG monoclonal antibody (Sigma, St.
Louis, MO, U.S.A.) was used at a concentration of
10 mg ml 1 and the FITC-conjugated secondary
antibody (Invitrogen Life Technologies, Carlsbad,
CA, U.S.A.) was used at a 1 : 1000 dilution. The slides
were viewed through a Ziess Axioscope ¯uorescence
microscope equipped with an FITC-®lter.
For immunoprecipitation analysis, cell extracts
were prepared in 1 ml of cold NP40 lysis buffer
(50 mM Tris±HCl, pH 7.5; 0.1 % NP-40; 250 mM
NaCl; 50 mM NaF; 5 mM EDTA). The extracts were
sonicated and then centrifuged at 13 000 g for
10 min at 48C to remove insoluble material. Protein
concentrations were determined using the Bio-Rad
protein assay system as directed. Immunoprecipitation reactions (0.5 mg ml 1) were carried out as
described previously (Muller-Weeks et al., 1998) with
one modi®cation; all washes were performed using
NP40 lysis buffer. Again, the M5 anti-FLAG monoclonal antibody was used at a concentration of
10 mg ml 1 and the anti-HA monoclonal antibody
(Covance) was used at a 1 : 1000 dilution. Proteins
recovered by immunoprecipitation were resolved by
10 % SDS±PAGE and visualized by Western blotting.
Denaturing and Non-denaturing Gel Electrophoresis
SDS±PAGE was performed using the method of
Laemmli (1970). Cell extracts were denatured by
adding an equal volume of 2 SDS±PAGE sample
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buffer (100 mM Tris±HCl, pH 6.8; 200 mM DTT; 4 %
SDS; 0.2 % bromophenol blue; 20 % glycerol) in the
presence (reducing) or absence (non-reducing) of 5 %
beta-mercaptoethanol. The samples were heated to
858C for 10 min and loaded directly onto a 10 %
SDS±polyacrylamide gel. Non-denaturing tricine polyacrylamide gel electrophoresis (10 %) was performed
by omitting SDS from the system described by
Schagger and von Jagow (1987). In this case, the
samples were prepared in the absence of BME and
were not heated prior to loading. Gels were run at
30 mA for 2 hr.
Western Blotting and Enzymatic Deglycosylation Studies
Western blotting was performed according to the
procedure of Towbin et al. (1979). Antibody binding
and wash conditions were as previously described
(Caradonna et al., 1996). Protein bands were
visualized using Sigma Fast BCIP/NBT (5-Bromo-4Chloro-3-Indolyl phosphate/ Nitro blue tetrazolium)
substrate as directed.
Deglycosylation of peripherin/rds was performed
using endoglycosidase H (Endo H) as outlined by New
England Biolabs (Beverly, MA, U.S.A.). Initially, 2 ml of
denaturing buffer (50 mM sodium citrate, pH 5.5)
were added to the extracts in a 15 ml reaction. The
extracts were denatured by heating to 1008C for
10 min. Subsequently, 1/10th volume of 10 G5
buffer (0.5 % SDS; 1 % b-mercaptoethanol) and 1 U of
endoglycosidase H were added and the reactions were
incubated at 378C overnight. Control extracts were
also prepared as described but lacked the enzyme.
Preparation and Labelling of ROS Membranes
Retinal ROS membranes were isolated from 50
frozen, dark-adapted bovine retinas (J.A. Lawson,
Lincoln, NE, U.S.A.). Disk membranes and plasma
membrane vesicles were isolated using ricin-agarose
and differential sucrose gradient centrifugation as
described (Boesze-Battaglia and Albert, 1989). The
ROS plasma membranes were eluted from the ricinagarose pellet with 1 M galactose in 0.1 M sodium
borate, pH 8.5. Both ROS plasma membrane vesicle
fractions and the isolated disk membranes were
washed with 10 mM Hepes, 1.0 mM EGTA. The
plasma membrane vesicles were resuspended in
500 ml of 10 mM Hepes, pH 7.4 and used within
24 hr of isolation. All manipulations were performed
under dim red light.
The phospholipid concentration of both ROS disk
and plasma membrane samples was determined as
described by Bartlett (1959) and modi®ed by Litman
(1973). Disk membranes were labelled with octadecylrhodamine B chloride (R18, Molecular Probes,
Junction City, OR, U.S.A.) at a concentration of
1 mol % relative to total phospholipid. Plasma
membrane vesicles were similarly labelled with
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5-(N-octadecanoyl) amino¯uorescein (F18, Molecular
Probes, Junction City, OR, U.S.A.). Labelling was
carried out in a minimum volume of ethanol for
30 min at room temperature as described (BoeszeBattaglia and Yeagle, 1992). Labelled membranes
were separated from unincorporated R18 or F18 by
passing the samples through a Sephadex G50
column and eluting with 100 mM NaCl, 10 mM
glycine pH 7.5.
Preparation and Labelling of COS Intracellular
Membranes
COS cell intracellular membranes were isolated
essentially as described by Oprian (1993). Brie¯y, cell
pellets were resuspended in 600 ml Tris±MgCl2 buffer
(10 mM Tris±HCl pH 7.2, 2 mM MgCl2, and 10 mM
glucose) and lysed by passage through a 26-gauge
needle two times. The resulting lysate was layered on
a 3.8 ml cushion of 37 % W/V sucrose in Tris±MgCl2
buffer and centrifuged at 18 000 rpm for 20 min
at 108C (XL70 Ultra Centrifuge, SW 60 rotor,
Beckmann Instrument, Papo Gilo, CA, U.S.A.). The
intracellular membranes were collected in a 500 ml
volume and an equal volume of Tris±MgCl2 buffer
was added to dilute the sucrose. Phosphate assays
were performed to determine the total phospholipid
content of the intracellular membranes. The membranes were then labelled with F18 as described above.
A total volume of 3 ml of labelled membrane was
collected from the Sephadex G50 column.
Resonance Energy Transfer Fusion Assays
The fusion between R18-labelled ROS plasma membrane vesicles and F18-labelled membranes (ROS disk
or intracellular COS) was measured using a wellcharacterized resonance energy transfer (RET) assay
(Struck et al., 1981; Partearroyo et al., 1994). The
fusion assays were performed at room temperature on a
Perkin-Elmer LS 50B spectro¯uorometer (Gaithersburg, MD, U.S.A.) equipped with a 96 well plate reader.
Fusion was initiated with addition of R18-labelled
plasma membranes (®nal phospholipid concentration  0.20 nM) to F18-labelled membranes (®nal
phospholipid concentration  0.40 nM) already present in the well. Fluorescence intensity was measured
at lex  460 nm (F18 excitation) and at lem  524 nm
(F18 emission) and lem  592 nm (R18 emission) over
a 2 min period. There was no additional change in R18
¯uorescence for 30 min. The extent of fusion
(DR  100) was calculated as a percent change in
R18 intensity over time as described previously
(Partearroyo et al., 1994). The change in R18 intensity
at a given time (DR) was computed as follows:
DR  I592 =I524  I592 T

I592 =I524  I592 I ;

where I524 and I592 are the ¯uorescence intensities at
524 and 592 nm, respectively. The subscripts T and I

represent a given time point and the initial time point
of each sample, respectively. The extent of fusion (i.e.,
percent change in R18) was determined by multiplying
each DR value by 100 and this value was normalized
to the calculated extent of fusion observed between
F18-labelled disks and R18-labelled plasma membrane.
This latter value was set as 100 % and all extents of
fusion (DR  100) were normalized to this standard.
The DR  100 value obtained with mock-transfected
cells was routinely subtracted from DR  100 of the
samples. This value was variable, accounting for 25±
40 % of DR measured for peripherin/rds expressing
cells. The ®nal Ca2 concentration in all assays was
100 nM. Fusion could be inhibited with the addition
of EDTA at a ®nal concentration of 10 mM.
For speci®city studies, F18-labelled COS intracellular
membranes were preincubated with PP-5 (72.5 nM)
at 378C for 20 min prior to the addition of R18labelled ROS plasma membrane. The sequence of the
PP-5 peptide is H2N-V-P-E-T-W-K-A-F-L-E-S-V-K-K-LCOOH.
3. Results
Construction and Expression of Peripherin/rds Deletion
Mutants
The peripherin/rds C-terminus is a 64 amino acid
extradiskal domain that spans amino acid residues
282±345. This region is highly conserved (78 %
amino acid identity) between human, bovine, canine,
feline and rodent species suggesting a functional
importance. Chou-Fasman and Robson-Garnier
analyses of the peripherin/rds C-terminus predict
three a-helical regions that are labelled 1, 2 and 3
in Fig. 1. To evaluate the functional signi®cance of
these a-helical domains, a series of C-terminal
truncation mutants were constructed. The deletion
endpoints were selected using the predicted secondary
structural analysis (Fig. 1). The D1 mutant, removes
residues 326±345, corresponding to the third predicted a-helical region. The D2 mutant, deletes
residues 317±345, truncating the second a-helical
region or fusion peptide domain (Boesze-Battaglia
et al., 1997, 1998). The D3 mutant removes residues
307±345, thus eliminating the entire fusion domain.
Finally, the D4 mutant truncates the entire Cterminus (residues 288±345) encompassing all
three a-helical regions. Of note, both the D2 and D4
mutants approximate disease-linked mutations shown
to co-segregate with retinal degenerative diseases
(Felbor et al., 1997; Kohl et al., 1997).
The full-length peripherin/rds and all mutants were
engineered with an amino-terminal FLAG-epitope tag
to facilitate detection. Following transient transfections into COS cells, protein expression was con®rmed
by immunohistochemical localization using monoclonal antibody against the FLAG-tag (M5, Sigma,
St. Louis, MO, U.S.A.) and FITC-conjugated secondary
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F IG . 1. Schematic representation of the peripherin/rds C-terminus and deletion mutants. Amino acid sequence of the
peripherin/rds C-terminus is presented (residues 282±345). Chou-Fasman and Robison-Garnier analyses of the region reveals
three, a-helical regions that are denoted by < and numbered 1, 2 and 3. Helix 2 is the previously characterized fusion domain
and the corresponding amino acid sequence is underlined. This sequence also corresponds to the peptide referred to as PP-5.
Four C-terminal deletion mutants were constructed to disrupt the a-helical structures and are denoted D1±D4. Deletion
endpoints are marked with an arrow and the length of each deletion is indicated on the right.

antibody. The full-length, FLAG-tagged peripherin/rds
is localized to the internal membranes of COS cells
(Fig. 2(A), panel 1). Importantly, control transfections
using pCI-neo vector alone are negative for speci®c
peripherin/rds immunoreactivity (Fig. 2(A), compare
panels 1 and 2). These results are consistent with
those previously reported by Goldberg et al. (1995) for
heterologously expressed peripherin/rds. Immuno¯uorescent localization of mutants D2 and D4
shows that the staining pattern is unchanged,
remaining con®ned to the intracellular membranes
(Fig. 2(A), panels 3 and 4). While it appears that
the D4 mutant may be expressed at higher levels
(as compared with wild-type and D2), Western blot
analysis described below, demonstrates that it is not
the case. Identical results were obtained for mutants
D1 and D3 (data not shown).
Peripherin/rds expression was also evaluated by
Western blot analysis using equivalent amounts of
protein extract (25 mg) derived from each transfected
sample. As shown in Fig. 2(B), the full-length
peripherin/rds and deletion mutants are expressed to
approximately equal levels and can be readily detected
using the FLAG-epitope tag. Full-length peripherin/
rds migrates as a 38 kDa protein. This is slightly
larger than the native peripherin/rds puri®ed from
ROS owing to the presence of the 1 kDa FLAG-tag.
Molecular weights of the peripherin/rds mutants
are reduced accordingly, ranging from 36 (D1) to
31.5 kDa (D4). It is also apparent that the peripherin/
rds proteins resolve as doublets or possibly, as triplets.
This is most likely due to the presence of both
glycosylated and non-glycosylated forms. Others have
observed similar doublet patterns under both in vivo
(Boesze-Battaglia et al., 1997) and in vitro conditions
(Wrigley et al., 2000). Collectively, these results
suggest that the epitope tag does not interfere with
protein expression or localization. In addition, progressive deletions of the C-terminus do not signi®-

cantly alter protein expression levels or cellular
localization in the COS cell system.

F IG . 2. Expression of the peripherin/rds constructs in COS
cells. (A) Immuno¯uorescent localization using M5 antiFLAG primary antibody and FITC-labelled secondary
antibody. Cells were transiently transfected with the fulllength peripherin/rds (panel 1), D2 (panel 3) and D4 (panel
4) constructs. Panel 2 shows that no immuno¯uorescence is
detected in control cells transfected with pCI-Neo vector
alone. (Note: The exposure time for panel 2 was increased in
order to visualize cell structure since no speci®c ¯uorescence
is detectable.) (B) Western blot analysis of full-length
peripherin/rds and each deletion mutant (D1±D4). Extracts
(25 mg) from transiently transfected COS cells were fractionated by 10 % SDS±PAGE under reducing conditions. The
proteins were analysed by Western blotting using M5 antiFLAG antibody. Molecular weight standards in kilodaltons
are indicated on the left.
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Biochemical Characterization
The consequences of these C-terminal mutations on
several well-established biochemical properties of
peripherin/rds were then examined. These features
include: (1) glycosylation, (2) association with rom-1
and (3) the ability to form higher order complexes.
Peripherin/rds contains three possible N-linked glycosylation sites. In ROS, peripherin/rds is glycosylated at
a single site, asparagine 229, located within the D2
intradiskal loop (Kedzierski et al., 1999). Goldberg
et al. (1995) have shown that heterologously
expressed peripherin/rds is incompletely glycosylated
with both modi®ed and unmodi®ed forms present in
extracts. To examine the effects of the C-terminal
deletions on glycosylation, extracts prepared from
transfected COS cells were treated with endoglycosidase H (Endo-H) as shown in Fig. 3. In untreated
extracts (
lanes), peripherin/rds migrates as
doublets (full-length, D1 and D2) or triplets (D3 and
D4). Upon Endo-H treatment ( lanes) however, all
samples resolve as a single, lower molecular weight
band. An HA-tagged Rom-1 was also included in this
analysis and there was no apparent change in the
presence or absence of Endo-H treatment indicating
that it is not glycosylated in this system (data not
shown). The glycosylation pattern associated with
full-length peripherin/rds and mutants D1 and D2 is
consistent with previous results (Goldberg et al.,
1995) and indicates that removing the terminal 29
amino acids does not markedly interfere with
glycosylation in this system. Interestingly, there is a
third, higher molecular weight band identi®able in
mutants D3 and D4, which suggests the use of
alternate glycosylation sites.
Peripherin/rds has been shown to complex noncovalently with a non-glycosylated homolog, rom-1
(Bascom et al., 1992). The contribution of the
peripherin/rds C-terminus to this complex formation
was determined by co-immunoprecipitation analysis
using extracts from cells co-transfected with each
peripherin/rds construct (D1, D2, D3, and D4) and
rom-1. For detection purposes, rom-1 was engineered
with a HA-tag and cloned into pCI-Neo. Extracts
prepared from COS cells co-transfected with the
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individual peripherin/rds constructs and rom-1 were
immunoprecipitated using anti-FLAG antibody
(detects peripherin/rds). The products were separated
by 10 % SDS±PAGE and analysed by Western blotting
with the anti-HA antibody (detects rom-1). Fig. 4(A)
shows that full-length peripherin/rds and each of the
mutants are able to co-precipitate the 39 kDa HAtagged rom-1 protein. Control reactions are presented
in Fig. 4(B). Rom-1 is not detected in FLAG-immunoprecipitates from mock-transfected cells or cells
transfected with peripherin/rds or rom-1 individually
(Fig. 4(B), lanes 1±3). In a reciprocal experiment, all
of the anti-HA immunoprecipitates were shown to
contain peripherin/rds (data not shown). Together
these results show that removal of the peripherin/rds
C-terminus does not eliminate its ability to interact
with rom-1.
Native peripherin/rds also forms covalently linked
homodimers, tetrameric and higher order oligomeric
complexes (Goldberg et al., 1995; Loewen and Molday, 2000). Of particular signi®cance are recent
studies by Boesze-Battaglia et al. (2000) showing
that a synthetic peptide corresponding to the peripherin/rds fusion domain (PP-5) can assume a homotetrameric state mediated through non-covalent
interactions between the a-helices. This suggested
that the C-terminus of peripherin/rds may participate
in the formation of homotetramers (oligomers)
through non-covalent interaction. We assessed the
ability of full-length peripherin/rds and each deletion
mutant to assume dimeric and oligomeric forms using
non-denaturing tricine gel electrophoresis. The
proteins were visualized by Western blotting with
FLAG antibody and the results are presented in Fig. 5.
Full-length peripherin/rds, as well as peripherin/rds
co-transfected with rom-1 predominantly form
dimeric (approximately 80 kDa) and higher order
oligomeric (5160 kDa) complexes. The same is
evident for mutants D1 and D2. Interestingly, while
mutant D3 is likewise able to form dimeric and higher
order complexes, a signi®cant monomeric band is
also visible. The D4 mutant is present exclusively
in monomeric and dimeric forms and is apparently
unable to ef®ciently form higher order complexes.
Analysis of Peripherin/rds Dependent Fusion

F IG . 3. Enzymatic deglycosylation studies. Extracts
(25 mg) prepared from transiently transfected COS cells
were treated with Endo H () or left untreated ( ) as
indicated. Proteins were fractionated by 10 % SDS±PAGE
under reducing conditions and transferred to nitrocellulose
for Western blot analysis using the anti-FLAG M5 antibody.
Each construct name is indicated below the lanes.

Full-length bovine peripherin/rds has been shown
to promote membrane fusion. The fusion domain
has been localized to residues 311±325 within the
C-terminus of the protein. To investigate how the
predicted secondary structural domains within the Cterminus contribute to membrane fusion, the peripherin/rds deletion mutants were studied for their ability
to promote membrane fusion. Using a RET method
(Struck et al., 1981; Partearroyo et al., 1994), the
fusion between intracellular COS cell membranes
containing the expressed peripherin/rds proteins and
bovine ROS plasma membrane vesicles was measured.
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F IG . 4. Immunoprecipitation of peripherin/rds and rom-1 complexes. (A) Extracts (0.5 mg ml 1) were prepared from COS
cells transiently co-transfected with rom-1 plus the indicated constructs and immunoprecipitated using the M5 anti-FLAG
antibody (detects peripherin/rds). The immunoprecipitates were fractionated by 10 % SDS±PAGE and then analyzed by
Western blotting using the anti-HA monoclonal antibody (detects rom-1). Molecular weight markers are indicated on the right
and the location of antibody heavy and light chains are indicated on the left. (B) Control reactions showing the absence of rom1 staining in immunoprecipitates from mock-transfected cells and cells transfected individually with rom-1 and peripherin/rds.
Immunoprecipitation reactions and Western blotting were performed as described in (A), however, fractionation was by 12.6 %
SDS±PAGE. Lanes: (1) mock-transfected COS cells; (2) cells transfected with HA-rom-1; (3) cells transfected with FLAGperipherin/rds; (4) cells co-transfected with HA-rom-1 and FLAG-peripherin/rds.

In this assay, each membrane species is labelled with a
distinct ¯uorescent probe (F18 or R18 as described in
the `Materials and Methods'). As the membranes fuse,
the lateral diffusion of the ¯uorescent probes within
the lipid bilayer allows them to come in close
proximity. This causes energy to be transferred from
F18 (excited at 460 nm) to R18, thereby indirectly
exciting R18. As shown in Fig. 6(A), when R18-

F IG . 5. Non-denaturing electrophoresis of full-length
peripherin/rds and the deletion mutants. Extracts (30 mg)
from cells transiently transfected with the indicated
constructs were fractionated by 10 % non-denaturing tricine
gel electrophoresis. The proteins were transferred to
nitrocellulose for Western blotting using anti-FLAG M5
monoclonal antibody. Monomeric, dimeric and higher order
complex protein forms are indicated by brackets on the left.
Molecular weight markers in kilodaltons are indicated on
the right.

labelled ROS plasma membrane vesicles are mixed
with F18-labelled COS cell membranes isolated from
cells expressing the full-length peripherin/rds, an
increase in R18 (solid line) and a decrease in F18
(dashed line) ¯uorescence intensity is observed.
Notably, the increase in ¯uorescence was speci®c for
only peripherin/rds containing COS cell membranes;
when COS cells were transfected with rom-1 alone,
no fusion was detected (data not shown). The increase
in R18 ¯uorescence intensity was quantitated as
described in the `Materials and Methods' and normalized to maximal fusion. Maximal fusion is designated
as that between R18-labelled plasma membrane
vesicles and F18-labelled disk membranes (containing
native peripherin/rds) (Fig. 6(B), bar 1). Fusion
mediated by COS cell membranes containing fulllength peripherin/rds is presented in Fig. 6(B), bar 2.
All assays were performed using equivalent amounts
of phospholipid (0.40 nM) and peripherin/rds expression was veri®ed by Western blot analysis as shown in
the inset. To con®rm the speci®city of the fusion as
that due to peripherin/rds, the F18-labelled COS cell
intracellular membranes were treated with PP-5, a
synthetic peptide, previously shown to inhibit diskplasma membrane and peripherin/rds LUV-plasma
membrane fusion. The addition of PP-5 resulted in a
decrease in the percent change in R18 ¯uorescence,
suggesting inhibition of membrane fusion (Fig. 6(C)).
Importantly, the addition of bradykinin or PP-1
(a synthetic peptide to the N-terminal domain of
peripherin/rds (Boesze-Battaglia et al., 1997)) had no
effect on fusion. The concentration of PP-5 added is
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F IG . 6. Resonance energy transfer from F18 to R18. (A) Presented above is a representative scan of the increase in R18
¯uorescence emission at 592 nm (solid line) and the concomitant decrease in F18 ¯uorescence emission at 524 nm (dashed
line) when F18-labelled COS cell membranes containing peripherin/rds fuse with R18-labelled ROS plasma membrane. The
excitation wavelength is 460 nm. (B) Maximal fusion between R18-labelled ROS plasma membrane and F18-labelled COS
cell membranes containing peripherin/rds or F18-labelled disk membranes. The RET assay was performed as described in
the `Materials and Methods' and maximal percent fusion was calculated. Western blot analysis was also performed to
con®rm peripherin/rds expression in both samples (shown in inset). Inset, lane 1 disk membrane peripherin/rds; Western
blot probed with monoclonal antibody 2B6 and lane 2, FLAG-tagged peripherin/rds in COS cell membranes; Western
probed with anti-FLAG antibody. (C) The percent change in R18 ¯uorescence over time (in sec) upon energy transfer when
R18-labelled ROS plasma membranes are mixed with F18-labelled COS cell membranes, in the presence [ÐWÐ] and absence
[ÐQÐ] of PP-5.
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equal to the amount that inhibits fusion in model
membrane studies.
A comparison of the percent maximal fusion
between ROS plasma membranes and COS cell
membranes expressing either the full-length or the
four peripherin/rds deletion mutants can be seen in
Fig. 7. In contrast to the full-length peripherin/rds,
very little to no fusion was detectable with any of the
four C-terminal deletion mutants. These values are in
fact equivalent or below those obtained with mocktransfected cells. Routinely, the ¯uorescence observed
with the mock-transfected samples corresponded to
2±3 % of maximal fusion and importantly no increase
in ¯uorescence intensity was observed over the
time course of the experiments with these cells. This
inability to promote fusion is not due to the level of
protein expression, since all membranes contained
similar levels of expressed protein as shown in the
inset of Fig. 7. Together these results suggest that
none of deletion mutants contained the minimal
structural requirements necessary to promote fusion
at a level consistent with that of the full-length
protein.
4. Discussion
The results presented herein con®rm and expand
upon those reported by Goldberg et al. (1995). As
described previously, peripherin/rds expressed in COS
cells localizes to intracellular membranes, is glycosylated, forms heterotetramers with rom-1, and can form
homodimers and homotetramers (Goldberg et al.,
1995; Loewen and Molday, 2000). Our results extend
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these ®ndings by showing that peripherin/rds
expressed in COS cells can function as a fusion protein
by promoting fusion between COS cell membranes
containing peripherin/rds and vesicles prepared from
ROS plasma membranes. The characteristics of fusion
between COS cell membranes and ROS plasma
membrane vesicles are identical to those observed
with the native disk membranes and puri®ed peripherin/rds. Speci®cally, it is dependent upon nanomolar
levels of calcium and can be inhibited by addition of
PP-5, the synthetic peptide mimicking the proposed
fusion domain of peripherin/rds. Moreover, it is speci®c
for ROS plasma membrane as the target (data not
shown), observations which suggest that the fusion
event is indeed dependent upon the presence of
peripherin/rds in the membranes and is not mediated
by any of the other putative fusion proteins likely to
also be present in COS intracellular membranes.
The present experiments were conducted to evaluate the role of the C-terminal a-helices of peripherin/
rds. To facilitate protein detection, an N-terminal
FLAG epitope tagged peripherin/rds construct was
generated for expression in COS cells. Importantly, our
data show that the presence of the N-terminal epitope
tag does not alter the expression, or the localization
of peripherin/rds to intracellular membranes. As
expected, the FLAG-tagged peripherin/rds formed
either homo-oligomers or hetero-oligomers with
rom-1. The presence of the N-terminal epitope tag
also did not alter the fusogenic function of peripherin/
rds.
Progressive deletion of the peripherin/rds C-terminus did not appear to alter signi®cantly protein

F IG . 7. RET fusion assay between R18-labelled plasma membrane vesicles and various target membranes. The percent
maximal fusion is shown for mixtures of R18-labelled plasma membrane vesicles and F18-labelled, disks (bar 1), or COS cell
membranes from cells transfected with full-length FLAG-peripherin/rds (bar 2), D1 mutant (bar 3), D2 mutant (bar 4), D3
mutant (bar 5) or D4 mutant (bar 6). Inset, Western blot probed with anti-FLAG antibody showing the amount of expressed
protein in each sample.
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expression or localization in the COS cell system.
However, the utility of COS cells is limited in that they
are not polarized neuronal cells and certainly lack
speci®c machinery required for transport/sorting. Our
results therefore, do not preclude the possibility that
the peripherin/rds C-terminus is important for directing localization of this protein in ROS. This question is
currently being addressed using peripherin/rds-GFP
fusion constructs to create transgenic Xenopus laevis
(Lee et al., 2001; Tam et al., 2001). Initial results are
con¯icting however, with one group reporting that
the C-terminus is required for proper targeting to ROS
(Tam et al., 2001) and another reporting that the
C-terminus is not required (Lee et al., 2001).
The C-terminal mutants also behave normally with
respect to glycosylation and complex formation with
rom-1. Interestingly, when the entire C-terminal
domain was removed in the D4 mutant, additional
slower migrating bands were seen (Fig. 3). It is
possible that the D4 mutant is somewhat misfolded,
thereby exposing a previously inaccessible glycosylation site, which resulted in the additional bands.
Alternatively, conformational changes resulting from
the loss of the entire C-terminus may have caused the
changes in migration. In either case, all protein forms
were reduced to a single non-glycosylated form in the
presence of Endo-H. Native ROS peripherin/rds forms
heterotetramers and higher order complexes with
rom-1 (Goldberg and Molday, 1996; Loewen and
Molday, 2000). Loewen and Molday (2000) have
presented evidence suggesting that the sites of noncovalent interactions between peripherin/rds and
rom-1 are within the D2 loop of peripherin/rds. Our
results showing complex formation between rom-1
and each of the four mutated forms of peripherin/rds
suggest that the C-terminus is most likely not the site
of interaction between peripherin/rds and rom-1 and
are consistent with previous results.
Prior work has identi®ed a region within the Cterminus of peripherin/rds proposed to be the fusion
domain of this protein (Boesze-Battaglia et al., 1997,
1998). This region corresponding to amino acids
311±325 is an amphiphilic a-helix (Boesze-Battaglia
et al., 1998), a secondary structure common to other
fusion proteins (White, 1990). Deletion mutants
within the C-terminus of peripherin/rds that either
disrupt (D2 mutant) or omit (D3 and D4 mutants)
this fusion domain, do not promote membrane fusion.
These observations provide strong support for our
conclusions that the fusogenic region of peripherin/
rds resides in the C-terminus and that the fusogenic
domain within the C-terminus lies between amino
acids 311±325. In addition, the D2 mutant approximates the stop mutation that is associated with a
retinal degenerative disease state described by Felbor
et al. (1997). Similarly, Kohl et al. (1997) have
described a retinal degenerative disease that is
associated with a second stop mutation in peripherin/rds corresponding to the D4 mutant. Our
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®ndings represent the ®rst biochemical abnormalities
associated with these mutated forms of peripherin/rds
found in either degenerative disease.
Interestingly, the truncation mutant (D1) which
lacks the last 20 amino acids of the C-terminus, but
which retains an intact fusion domain (i.e., amino
acids 311±325) did not promote fusion. This observation was not altogether unexpected since the antiperipherin/rds monoclonal antibody 2B6, partially
inhibits disk-plasma membrane and peripherin/rds
LUV-plasma membrane fusion. The epitope for this
monoclonal antibody resides within the terminal 30
amino acids of the protein (Connell and Molday,
1990). Most likely, the 20 amino acid region missing
in the D1 mutant is itself not a fusion domain because
in vitro studies using a synthetic peptide mimicking
this region did not by itself promote fusion between
ROS plasma membrane vesicles and lipid vesicles
(Boesze-Battaglia et al., 1997). Of note, Stefano et al.
(2002) have recently generated a peripherin/rds
mutant lacking the C-terminal 10 amino acids and
expressed this protein in MDCK cells. This mutation
does not disrupt the third a-helical domain and is
capable of mediating membrane fusion. Similar results
were also seen in COS cells (Boesze-Battaglia, unpubl.
res).
Our previous studies have suggested that the fusion
competent form of the fusion peptide (a.k.a. PP-5) and
by inference, peripherin/rds, requires the formation of
a homotetrameric complex. It is unlikely, however,
that the failure of the D1 mutant to promote fusion
can be ascribed to an inability of this mutant to form
tetramers because evidence of homo-oligomer formation was detected with this mutant (Fig. 5). The
®nding that the D1 mutant forms higher order
complexes but is not fusion competent indicates that
formation of a tetrameric state is not solely responsible
for conferring fusion competency. It can also be
concluded that domains within the C-terminus, other
than the fusion domain (amino acids 311±322), are
required for the formation of a fusion competent form
of peripherin/rds. Thus, the region corresponding to
the terminal 20 amino acids most likely aids in
promoting the fusion competency of this protein. Such
domains have been described for viral membrane
fusion proteins and intracellular traf®cking fusion
proteins as contributing to the formation of hairpins
(a.k.a., SNAREpins), necessary to form a fusion pore
(Weber et al., 1998). How these regions interact and
their structural identity remains to be determined.
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